Send feedback

CAPN3 p.Arg490Gln

c.1469G>A · rs121434548 · VCV17622

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 19 submitters
AlphaMissense
likely pathogenic
0.9588 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0198%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PM3_VeryStrong PP3 PP4 PM5

Curation rationale (ClinGen, verbatim)

The NM_000070.3: c.1469G>A variant in CAPN3 is a missense variant predicted to cause substitution of arginine by glutamine at amino acid 490 (p.Arg440Gln). This variant has been detected in at least 16 individuals with limb girdle muscular dystrophy (PMID: 26404900, 18055493, 10330340, 22378277, 22443334, 18854869), including in a homozygous state in at least four cases (1.0 pt; PMID: 18055493, 10330340, 22443334) and confirmed in trans with a pathogenic variant in three cases (c.550del p.(Thr184ArgfsTer36), 3.0 pts, PMID: 26404900, 18854869, 22378277) (PM3_Very Strong). At least one patient with this variant displayed progressive limb girdle muscle weakness or a clinical suspicion of LGMD (PP4). The highest population minor allele frequency of this variant is 0.0001846 (3/16248 exome alleles) in the African/African American population in gnomAD v2.1.1, which is greater than the LGMD VCEP threshold (<0.0001) for PM2_Supporting (criterion not met). The computational predictor REVEL gives a score of 0.94, which is above the VCEP threshold of 0.70, evidence that correlates with impact to CAPN3 function (PP3). Another missense variant at the same codon, c.1468C>T p.(Arg490Trp), has been classified as pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PM3_Very Strong, PP4, PP3, PM5.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9588likely pathogenic ✓ concordant with ClinVar
REVEL0.935strongly pathogenic-leaning
SaProtLLR -13.43damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.8, phastCons 1
Regional constrainto/e 0.96unconstrained · MANE · 52 kb · p 0.21 · regional, not allelic
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0198% European (non-Finnish) · 234/1,179,982 alleles
Filtering AF 0.0177% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0169%
Overall 0.0156% 252/1,614,044 alleles · ultra-rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.0198% 5,043
Remaining individualsnot grpmax-eligible 0.0112% 8,930
African / African-American 0.00666% 15,004
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,606
Admixed American 0.00333% 30,003
East Asian 0.00223% 44,838
South Asian 0.0022% 45,537

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CAPN3
Protein
p.Arg490Gln
Coding
c.1469G>A
MANE Select
NM_000070
dbSNP
rs121434548
Type
single nucleotide variant
Location
chr15:42401755 (GRCh38)
Gene constraint
LOEUF 0.896 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 79.18 · 5 PDB
Residue 490
the 'domain iii' region; a UniProt-annotated variant site (in lgmdr1)
Full CAPN3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/capn3-p-arg490gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown